GlassScriptPhysician profile
Jack W Janoe
NPI 1922009018
$2,397.25
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $747 · 2020: $345 · 2021: $1,018 · 2022: $287.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,079.93 | 2019-2021 | |
| Pfizer INC. | $399.88 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $287.21 | 2022 | |
| Amgen INC. | $246.67 | 2019-2021 | |
| Novo Nordisk INC | $85.01 | 2019-2021 | |
| Si-Bone, INC. | $59.95 | 2019 | |
| Lilly USA, LLC | $54.33 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $33.85 | 2021 | |
| Allergan, INC. | $32.57 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.22 | 2020 | |
| Eisai INC. | $22.60 | 2021 | |
| Antares Pharma, INC. | $19.66 | 2020 | |
| Merck Sharp & Dohme LLC | $12.89 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.59 | 2019 | |
| Glaxosmithkline, LLC. | $12.55 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $11.34 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Janoe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.